Executive Summary
MedTech Innovator's 2027 accelerator takes medtech startups anywhere that target the U.S. market. It lists more than $700,000 in prize capital across four competitions. Applications close December 1, 2026.
The program fee is $15,000, payable in cash or as a $50,000 SAFE note. On the BARDA Vantage track a BARDA scholarship covers the fee. Vantage's separate non-dilutive funding round closed October 22, 2026.
Solicitation at a Glance
- Organizer: MedTech Innovator; the Vantage track is a BARDA accelerator
- Funding: $700,000+ in prize capital across four competitions
- Fee: $15,000 cash or a $50,000 SAFE (the AHA and ASPS tracks require the SAFE)
- Deadline: December 1, 2026
- Duration: Five months
Think your company qualifies? Talk with BW&CO before the December 1 deadline.
Eligibility Requirements
- Who can apply: Companies anywhere with the U.S. as a target market
- Commitment: A founder or C-suite lead must take part for all five months
How to Apply
- Choose: Your track
- Apply: On medtechinnovator.org by December 1, 2026
Is This Opportunity a Good Fit for Your Company?
It fits medical device and diagnostics startups that can commit a founder for five months and weigh the fee or SAFE.
How BW&CO Can Help
BW&CO has helped deep-tech and dual-use founders secure more than $350M in non-dilutive funding. For accelerator applications like this one, we help you:
- Review your story and milestones before you submit
- Weigh the fee against the SAFE
- Plan BARDA and NIH funding alongside the program
- Prepare for the competitions
- Map next-step federal funding
Plan Your MedTech Innovator Application
Frequently Asked Questions
Is this a grant?
No. It is an accelerator with prize competitions.
Is Vantage funding open now?
No. That round closed October 22, 2026.
Can BW&CO help with an application?
Yes. We review applications and plan the federal funding that comes next. Book a call with our team.